STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
COLL COLLEGIUM PHARMACEUTICALS INCORPORATED StockScouter® Report
5
StockScouter® Score
COLLEGIUM PHARMACEUTICALS INCORPORATED, a small cap value company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Short-term relative price momentum exhibits meaningful strength. Postive
- One or more less experienced analysts has modestly increased quarterly earnings estimates for COLL. Positive/Neutral
Concerns
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- The multi-period measure of relative price change and consistency is below average. Negative/Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, value stocks will be in favor, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
C
C
D